Ipsen gets UK approval for Dysport to treat upper limb spasticity in children with cerebral palsy

This article was originally published here

Dysport, an injectable form of a botulinum neurotoxin type A product, is a substance derived from Clostridium bacteria producing botulinum toxin type A (BoNT-A), which blocks the effective

The post Ipsen gets UK approval for Dysport to treat upper limb spasticity in children with cerebral palsy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply